|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 40051 |
FusionGeneSummary for TTL_EIF6 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TTL_EIF6 | Fusion gene ID: 40051 | Hgene | Tgene | Gene symbol | TTL | EIF6 | Gene ID | 150465 | 3692 |
| Gene name | tubulin tyrosine ligase | eukaryotic translation initiation factor 6 | |
| Synonyms | - | CAB|EIF3A|ITGB4BP|b(2)gcn|eIF-6|p27(BBP)|p27BBP | |
| Cytomap | 2q14.1 | 20q11.22 | |
| Type of gene | protein-coding | protein-coding | |
| Description | tubulin--tyrosine ligase2410003M22Rik | eukaryotic translation initiation factor 6B4 integrin interactoreukaryotic translation initiation factor 3Ap27 beta-4 integrin-binding protein | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q8NG68 | P56537 | |
| Ensembl transtripts involved in fusion gene | ENST00000233336, ENST00000460450, | ENST00000374436, ENST00000374443, ENST00000374450, ENST00000462894, | |
| Fusion gene scores | * DoF score | 2 X 2 X 1=4 | 5 X 6 X 3=90 |
| # samples | 2 | 6 | |
| ** MAII score | log2(2/4*10)=2.32192809488736 | log2(6/90*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: TTL [Title/Abstract] AND EIF6 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF815368 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000233336 | ENST00000374436 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
| intron-3UTR | ENST00000233336 | ENST00000374443 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
| intron-3UTR | ENST00000233336 | ENST00000374450 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
| intron-intron | ENST00000233336 | ENST00000462894 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
| intron-3UTR | ENST00000460450 | ENST00000374436 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
| intron-3UTR | ENST00000460450 | ENST00000374443 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
| intron-3UTR | ENST00000460450 | ENST00000374450 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
| intron-intron | ENST00000460450 | ENST00000462894 | TTL | chr2 | 113281232 | - | EIF6 | chr20 | 33866916 | - |
Top |
FusionProtFeatures for TTL_EIF6 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| TTL | EIF6 |
| Catalyzes the post-translational addition of a tyrosineto the C-terminal end of detyrosinated alpha-tubulin.{ECO:0000269|PubMed:25908662}. | Binds to the 60S ribosomal subunit and prevents itsassociation with the 40S ribosomal subunit to form the 80Sinitiation complex in the cytoplasm. Behaves as a stimulatorytranslation initiation factor downstream insulin/growth factors.Is also involved in ribosome biogenesis. Associates with pre-60Ssubunits in the nucleus and is involved in its nuclear export.Cytoplasmic release of TIF6 from 60S subunits and nuclearrelocalization is promoted by a RACK1 (RACK1)-dependent proteinkinase C activity (PubMed:10085284, PubMed:14654845,PubMed:21536732). In tissues responsive to insulin, controls fattyacid synthesis and glycolysis by exerting translational control ofadipogenic transcription factors such as CEBPB, CEBPD and ATF4that have G/C rich or uORF in their 5'UTR. Required for ROS-dependent megakaryocyte maturation and platelets formation,controls the expression of mitochondrial respiratory chain genesinvolved in reactive oxygen species (ROS) synthesis (Bysimilarity). Involved in miRNA-mediated gene silencing by the RNA-induced silencing complex (RISC). Required for both miRNA-mediatedtranslational repression and miRNA-mediated cleavage ofcomplementary mRNAs by RISC (PubMed:17507929). Modulates cellcycle progression and global translation of pre-B cells, itsactivation seems to be rate-limiting in tumorigenesis and tumorgrowth (By similarity). {ECO:0000255|HAMAP-Rule:MF_03132,ECO:0000269|PubMed:10085284, ECO:0000269|PubMed:14654845,ECO:0000269|PubMed:17507929, ECO:0000269|PubMed:21536732}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TTL_EIF6 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TTL_EIF6 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TTL_EIF6 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TTL_EIF6 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | EIF6 | C0019693 | HIV Infections | 1 | CTD_human |
| Tgene | EIF6 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|